A detailed history of Forte Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Forte Capital LLC holds 3,800 shares of AMGN stock, worth $1.1 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
3,800
Previous 3,819 0.5%
Holding current value
$1.1 Million
Previous $1.19 Million 2.6%
% of portfolio
0.15%
Previous 0.15%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$309.38 - $337.38 $5,878 - $6,410
-19 Reduced 0.5%
3,800 $1.22 Million
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $9,721 - $11,814
37 Added 0.98%
3,819 $1.19 Million
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $94,642 - $114,245
-352 Reduced 8.51%
3,782 $1.08 Million
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $27,615 - $31,153
108 Added 2.68%
4,134 $1.19 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $3,935 - $4,886
-18 Reduced 0.45%
4,026 $1.08 Million
Q2 2023

Aug 09, 2023

SELL
$214.27 - $253.37 $39,639 - $46,873
-185 Reduced 4.37%
4,044 $897,000
Q1 2023

May 11, 2023

SELL
$225.79 - $275.2 $73,607 - $89,715
-326 Reduced 7.16%
4,229 $1.02 Million
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $28,399 - $36,085
124 Added 2.8%
4,555 $1.2 Million
Q3 2022

Oct 21, 2022

BUY
$224.46 - $253.15 $46,687 - $52,655
208 Added 4.93%
4,431 $999,000
Q2 2022

Aug 09, 2022

SELL
$230.71 - $256.74 $29,761 - $33,119
-129 Reduced 2.96%
4,223 $1.03 Million
Q4 2021

Jan 20, 2022

SELL
$198.88 - $227.6 $823,363 - $942,264
-4,140 Reduced 48.75%
4,352 $979,000
Q3 2021

Oct 27, 2021

SELL
$212.27 - $248.7 $4.74 Million - $5.55 Million
-22,314 Reduced 72.43%
8,492 $1.81 Million
Q2 2021

Jul 28, 2021

SELL
$233.58 - $259.14 $123,563 - $137,085
-529 Reduced 1.69%
30,806 $7.51 Million
Q1 2021

Apr 22, 2021

SELL
$221.91 - $258.6 $41,275 - $48,099
-186 Reduced 0.59%
31,335 $7.8 Million
Q4 2020

Jan 19, 2021

SELL
$216.38 - $257.67 $76,165 - $90,699
-352 Reduced 1.1%
31,521 $7.25 Million
Q3 2020

Nov 03, 2020

BUY
$234.65 - $260.95 $62,886 - $69,934
268 Added 0.85%
31,873 $8.1 Million
Q2 2020

Jul 09, 2020

BUY
$197.81 - $242.74 $1.19 Million - $1.47 Million
6,041 Added 23.63%
31,605 $7.45 Million
Q1 2020

Apr 08, 2020

BUY
$182.24 - $241.7 $47,017 - $62,358
258 Added 1.02%
25,564 $5.18 Million
Q4 2019

Jan 10, 2020

BUY
$189.21 - $243.2 $25,354 - $32,588
134 Added 0.53%
25,306 $6.1 Million
Q3 2019

Oct 09, 2019

BUY
$174.11 - $208.62 $352,050 - $421,829
2,022 Added 8.73%
25,172 $4.87 Million
Q2 2019

Jul 16, 2019

BUY
$166.7 - $195.41 $80,849 - $94,773
485 Added 2.14%
23,150 $4.27 Million
Q1 2019

Apr 08, 2019

BUY
$180.87 - $203.88 $47,568 - $53,620
263 Added 1.17%
22,665 $4.31 Million
Q4 2018

Jan 24, 2019

BUY
$178.4 - $208.25 $98,120 - $114,537
550 Added 2.52%
22,402 $4.36 Million
Q3 2018

Oct 16, 2018

BUY
$185.29 - $208.89 $335,560 - $378,299
1,811 Added 9.04%
21,852 $4.53 Million
Q2 2018

Jul 13, 2018

BUY
$166.05 - $186.51 $177,673 - $199,565
1,070 Added 5.64%
20,041 $3.7 Million
Q1 2018

Apr 17, 2018

BUY
$169.43 - $198.0 $225,341 - $263,340
1,330 Added 7.54%
18,971 $3.23 Million
Q4 2017

Jan 22, 2018

BUY
$168.79 - $188.59 $85,238 - $95,237
505 Added 2.95%
17,641 $3.07 Million
Q3 2017

Oct 11, 2017

BUY
$167.29 - $191.0 $2.87 Million - $3.27 Million
17,136
17,136 $3.2 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Forte Capital LLC Portfolio

Follow Forte Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forte Capital LLC , based on Form 13F filings with the SEC.

News

Stay updated on Forte Capital LLC with notifications on news.